https://scholars.lib.ntu.edu.tw/handle/123456789/620381| Title: | Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study | Authors: | Hsieh, Meng-Jer Chen, Ning-Hung Cheng, Shih-Lung Tao, Chi-Wei Wei, Yu-Feng Wu, Yao-Kuang Chan, Ming-Cheng Liu, Shih-Feng Hsu, Wu-Huei Yang, Tsung-Ming Lin, Ming-Shian Liu, Ching-Lung PING-HUNG KUO Tsai, Ying-Huang |
Keywords: | LABA/LAMA therapy; Taiwan; chronic obstructive pulmonary disease; cohort study; indacaterol/glycopyrronium; moderate-to-severe exacerbation; propensity score matching; tiotropium/olodaterol; umeclidinium/vilanterol | Issue Date: | 2022 | Publisher: | DOVE MEDICAL PRESS LTD | Journal Volume: | 17 | Start page/Pages: | 967 | Source: | International journal of chronic obstructive pulmonary disease | Abstract: | Long-acting beta-agonists (LABA) and long-acting muscarinic antagonists (LAMA) combination therapy improved lung function and health-related quality-of-life and reduced exacerbation rates and dyspnea in symptomatic chronic obstructive pulmonary disease (COPD) patients. We compared the real-world effects of three fixed-dose LABA/LAMA combinations for COPD in Taiwan. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/620381 | ISSN: | 1178-2005 | DOI: | 10.2147/COPD.S353799 |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.